CAS: 72702-95-5 - Ponalrestat
Formula:C17H12BrFN2O3
InChI:InChI=1/C17H12BrFN2O3/c18-11-6-5-10(14(19)7-11)9-21-17(24)13-4-2-1-3-12(13)15(20-21)8-16(22)23/h1-7H,8-9H2,(H,22,23)
- Synonyms:
- Ponalrestat [USAN:INN:BAN]
- 1-Phthalazineacetic acid, 3-((4-bromo-2-fluorophenyl)methyl)-3,4-dihydro-4-oxo-
- 3-(4-Bromo-2-fluorobenzyl)-3,4-dihydro-4-oxo-1-phthalazineacetic acid
- Ici 128,436
- Ponalrestatum
- Ponalrestatum [Latin]
- Unii-2Cv0A5G64E
- [3-(4-Bromo-2-Fluorobenzyl)-4-Oxo-3,4-Dihydrophthalazin-1-Yl]Acetic Acid
1-Phthalazineaceticacid, 3-[(4-bromo-2-fluorophenyl)methyl]-3,4-dihydro-4-oxo-
CAS:72702-95-5
Formula:
C17H12BrFN2O3
Purity:
97%
Color and Shape:
Solid
Molecular weight:
391.1912
Ref: AN-AG005PTL
25mg | 113.00 € | |
50mg | 187.00 € | |
100mg | 228.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
Ponalrestat
CAS:72702-95-5
Ponalrestat is an aldose reductase inhibitor.
Formula:
C17H12BrFN2O3
Purity:
99.86%
Color and Shape:
Solid
Molecular weight:
391.19
Ref: TM-T2013
10mg | 46.00 € | |
25mg | To inquire | |
50mg | To inquire | |
1ml*10 (DMSO) | 50.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Ponalrestat
CAS:72702-95-5
Ponalrestat is a drug that has been developed to treat metabolic disorders, such as diabetic …
Formula:
C17H12BrFN2O3
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
391.19 g/mol
Ref: 3D-FP102755
25mg | 98.00 € | |
50mg | 146.00 € | |
100mg | 219.00 € | |
250mg | 430.00 € | |
500mg | 633.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Ponalrestat - Bio-X ™
CAS:72702-95-5
This product is part of our Bio-X ™ Range. These products are aimed at life …
Formula:
C17H12BrFN2O3
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
391.19 g/mol
Ref: 3D-BP300109
10mg | 109.00 € |
Estimated delivery in United States, on Monday 13 May 2024